Business Standard

Tuesday, December 24, 2024 | 01:33 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Aurobindo Pharma confident of growth despite regulatory action, drug recall

The company said it was confident that the contamination in valsartan will not spread to other products

Aurobindo Pharma
Premium

Aurobindo Pharma | Photo: Wikipedia

BS Reporter Hyderabad
Drug major Aurobindo Pharma Ltd said on Monday it expects regulatory action leading to the worldwide recall of its hypertension product valsartan will not impact growth.
 
The company said it was confident that the contamination in valsartan will not spread to other products.

"From a cleaning

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in